Value-based insurance design copayment reductions sustained medication adherence 2 years into policy implementation and were most effective in patients with poor adherence before policy implementation.
Daryl Wansink, PhD
Advertisement
Articles by Daryl Wansink, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5